The National Time Service Center in Xi'an, Shaanxi province. [Photo/VCG] China's national security agency revealed on Sunday that the United States National Security Agency (NSA) has, since 2022, ...
Copyright 2025 The Associated Press. All Rights Reserved. Copyright 2025 The Associated Press. All Rights Reserved. A woman looks at shoes at a Sam’s Club ...
Abstract: High-fidelity synthetic tabular data generation is crucial, given that downstream tasks and data analysis typically require large amounts of tabular data. However, existing methods struggle ...
– 2L MTAP-del pancreatic cancer median progression free survival (mPFS) 7.2 months with an objective response rate (ORR) of 25% – – Combination studies with RAS(ON) inhibitors ongoing, data ...
Sign up for Chalkbeat’s free weekly newsletter to keep up with how education is changing across the U.S. Charles Longshore distinctly remembers the tipping point ...
A new study suggests phone bans can improve students' focus and grades. When one Florida school district banned cellphones, disciplinary issues initially spiked as schools worked to enforce the new ...
GSK may be happy with the latest readouts from two Hansoh-partnered antibody-drug conjugates, but the Big Pharma’s oncology R&D chief told Fierce to “stay tuned” for the company’s own data. The ...
Abstract: With the rapid advancement of Artificial Intelligence (AI) technologies, their applications are expanding across increasingly diverse domains. As critical infrastructure supporting AI ...
The “placebo-adjusted” weight loss achieved by Metsera’s drug at 28 weeks of treatment is roughly equal to the 13% achieved by Zebpound at the same stage in a Phase 3 study called Surmount-1, Risinger ...
School of Chemical Engineering, Guangdong Provincial Engineering Technology Research Center of Petrochemical Corrosion and Safety, Guangdong University of Petrochemical Technology, Maoming, Guangdong ...
Merck (NYSE:MRK) reported positive results from late-stage studies on a new oral treatment which combines two drugs, doravirine and islatravir, for adults with HIV-1. The studies looked at adults ...
NEW HAVEN, Conn., Oct. 14, 2025 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback